Chen et al. reported that eIF4A2 dysfunction, induced by genetic knockdown or inhibition, suppresses colorectal cancer cell invasion, cell migration, and sphere formation as well as increases tissue sensitivity to oxaliplatin both in vivo and in vitro (Chen et al., 2019). The gene discussed is EIF4A2; the disease is colorectal cancer.